Volume 7, Number 6—December 2001
Research
The Serologic Response to Cryptosporidium in HIV-Infected Persons: Implications for Epidemiologic Research
Table 1
Summary of antibody responses for the 11 cases and their respective controls
Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | |
---|---|---|---|---|---|---|---|---|
Mean | 2,784c | 414 | 2,117c | -17 | 1,594 | 85 | 1,531 | 5 |
Max | 12,224 | 973 | 11,247 | 157 | 9,264 | 217 | 9,239 | 69 |
Min | 102 | 178 | -866 | -144 | 36 | 41 | -5 | 47 |
Median | 1,334d | 329 | 433d | -32 | 140 | 56 | 71d | 1 |
S.D. | 3,560 | 237 | 3,531 | 84 | 2,880 | 53 | 2,884 | 36 |
N | 11 | 22 | 11 | 22 | 11 | 22 | 11 | 22 |
aIgG response after the date of clinical cryptosporidiosis diagnosis.
bDifference in IgG response between a sample taken before and after date of cryptosporidiosis diagnosis.
cCase value is significantly different from control value (p<0.05).
dCase value is significantly different from control value (p<0.01).
IgG = immunoglobulin G; TX17 = Triton antigen; SD = standard deviation.